TH07
also TH-07, Triple Hair
- Phase 3 topical · minoxidil + finasteride + latanoprost · Triple Hair · trial NCT07435012 · developer page · sponsor targets Dec 2027 for phase 3 primary completion (registry estimate) (said Mar 2026)
Once-daily topical spray of minoxidil, finasteride and latanoprost by Triple Hair, in phase 3 for men
Finasteride/latanoprost/minoxidil is a topical combination drug which is under development for the treatment of alopecia. It is specifically a combination of finasteride (Propecia) (0.1%), a 5α-reductase inhibitor (5α-RI); latanoprost (Xalatan) (0.03%), a prostaglandin F2α analogue and prostaglandin F receptor agonist; and minoxidil (Rogaine) (5%), a KATP potassium channel opener. All three of these drugs have individually been shown to stimulate hair growth in the setting of alopecia, and both finasteride and minoxidil are approved and widely used for treatment of alopecia. Finasteride/latanoprost/minoxidil is under development by Triple Hair. As of December 2023, the drug is in phase 2 clinical trials.
Read “Finasteride/latanoprost/minoxidil” on Wikipedia · text from Wikipedia, CC BY-SA 4.0
Information, not medical advice. Talk to a licensed doctor or pharmacist before starting or changing a treatment.
Research 1
All on OpenAlex →Posts
— no r/tressless threads found for TH07 yet
View more on Reddit →